Viking Therapeutics Announces Results from Phase 1 Clinical

/PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Related Keywords

, Drug Administration , Twitter , Ligand Pharmaceuticals Incorporated , Prnewswire Viking Therapeutics Inc , Therapeutics Inc , Nasdaq , Placebo Adjusted Mean Weight Loss , From Baseline , Observed After , Obesity Planned , Brian Lian , Body Weight Following , Reported Adverse Events Following , Viking Therapeutics , Ligand Pharmaceuticals , Nc ,